Listeriosis Complicating Infliximab Treatment in Crohn's Disease
Journal Title: Journal of Clinical Gastroenterology and Treatment - Year 2016, Vol 2, Issue 2
Abstract
Listeria monocytogenes, a gram-positive rod, infects the central nervous system in neonates, pregnant woman and those immunosuppressed by naturally occurring illnesses and by therapeutic agents, including agents such as infliximab. We report here the first published case of Listeriosis complicating Infliximab therapy in Crohn's disease in Australia.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP343672
- DOI 10.23937/2469-584X/1510024
- Views 166
- Downloads 0
Are Patients Hospitalized with Cirrhosis and Ascites Receiving Appropriate Diagnostic Paracentesis?
Background and Aim: Ascites is the most common complication of cirrhosis, and is associated with increased mortality. Diagnostic paracentesis is recommended for patients who are admitted to the hospital with ascites. How...
Visceral and Cutaneous Sarcoma Kaposi in a Patient with Ulcerative Colitis: Case Report and Review of the Literature
Sarcoma Kaposi is rare and most commonly affects the skin. Herein, we present a patient with ulcerative colitis, who developed intestinal Kaposi's sarcoma only six months after being diagnosed with ulcerative colitis. Th...
Effect of EGF on Bax, Bcl-2 and Fas Expression in Ulcerous Disease and N87 Cell Line
To evaluate the effect of EGF in primary culture of ulcer patients and N87 cell line on expressions of apoptotic genes. Ulcer patients who applied to Gastroenterology Clinic of Mersin University Medical Faculty were incl...
Listeriosis Complicating Infliximab Treatment in Crohn's Disease
Listeria monocytogenes, a gram-positive rod, infects the central nervous system in neonates, pregnant woman and those immunosuppressed by naturally occurring illnesses and by therapeutic agents, including agents such as...
The Role of Wide Area Transepithelial Sampling WATS 3D as an Adjunct to Standard Forceps Biopsy in Barrett's
Barrett's esophagus requires surveillance to monitor for dysplasia and esophageal adenocarcinoma. New methods have been developed to detect dysplasia and esophageal adenocarcinoma. One of these methods, the wide area tra...